دورية أكاديمية
Percutaneous endovascular intervention for left ventricular assist device outflow graft obstruction: A single-center experience.
| العنوان: | Percutaneous endovascular intervention for left ventricular assist device outflow graft obstruction: A single-center experience. |
|---|---|
| المؤلفون: | Wallace R; Department of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center/MedStar Georgetown University Hospital Center, Washington, DC, USA., Rogers T; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA; Cardiovascular Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Slack M; Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA., Sheikh FH; Advanced Heart Failure Program, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center/MedStar Georgetown University Hospital, Washington, DC, USA., Balsara K; Advanced Heart Failure Program, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center/MedStar Georgetown University Hospital, Washington, DC, USA., Weissman G; Department of Cardiology, MedStar Heart and Vascular Institute, MedStar Washington Hospital Center/MedStar Georgetown University Hospital Center, Washington, DC, USA., Satler LF; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA., Waksman R; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA. Electronic address: ron.waksman@medstar.net., Ben-Dor I; Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA. |
| المصدر: | Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2024 May 13. Date of Electronic Publication: 2024 May 13. |
| Publication Model: | Ahead of Print |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: United States NLM ID: 101238551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0938 (Electronic) Linking ISSN: 18780938 NLM ISO Abbreviation: Cardiovasc Revasc Med Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: New York, NY : Elsevier, c2005- |
| مستخلص: | Background: Outflow graft obstruction (OGO) is an uncommon yet life-threatening complication in patients with left ventricular assist devices (LVADs). In this retrospective, single-center case series, we identify the baseline demographics and presenting features of patients who develop LVAD OGO and the procedural details and outcomes surrounding percutaneous endovascular intervention (PEI). Methods: We conducted a retrospective review of patients with LVADs at our institution between January 2010 and February 2023 who developed OGO and were treated with PEI. Details of the PEI including procedure time, fluoroscopy time, contrast use, stent size, number of stents, change in gradient, and change in flow after intervention were collected. Results: A total of 12 patients who had 14 cases of OGO were identified from January 2010 to February 2023. The average age at presentation was 64.78 years. Nine of the 14 cases occurred in male patients. Eleven of the 14 cases occurred with Heartware devices (2 recurrences), 2 in Heartmate 2 and 1 in Heartmate 3. Notable procedural details include a mean procedure time of 90.86 min and mean contrast use of 162.5 mL. The initial gradient across the OGO was reduced by an average of 72 %, to a mean post-PEI of 11.57 mmHg. The average number of stents to achieve this gradient was around 2.08, with the most common stent diameter being 10 mm. Thirty-day mortality after PEI was 7 % (1/14) in this high-risk patient population. Conclusion: In our single-center experience, PEI can be a safe and effective treatment for LVAD OGO. Competing Interests: Declaration of competing interest Toby Rogers – Consultant: Edwards Lifesciences, Medtronic, Boston Scientific; Advisory board: Medtronic, Boston Scientific; Equity: Transmural Systems; Intellectual property: co-inventor on patents, assigned to NIH. Michael Slack – Proctor: Abbott. Farooq H. Sheikh – Institutional research support: Abbott, Alnylam, Ionis, BridgeBio; Speaker fee (educational conferences): Abbott. Gaby Weissman – Director of an academic cardiac computed tomography core lab with institutional contracts with Abbott, Boston Scientific, Medtronic, and Neovasc. Ron Waksman – Advisory Board: Abbott Vascular, Boston Scientific, Medtronic, Philips IGT, Pi-Cardia Ltd.; Consultant: Abbott Vascular, Append Medical, Biotronik, Boston Scientific, JC Medical, MedAlliance/Cordis, Medtronic, Philips IGT, Pi-Cardia Ltd., Swiss Interventional/SIS Medical AG, Transmural Systems Inc.; Institutional Grant Support: Biotronik, Medtronic, Philips IGT; Investor: Append Medical, Pi-Cardia Ltd., Transmural Systems Inc. All other authors — None. (Copyright © 2024. Published by Elsevier Inc.) |
| فهرسة مساهمة: | Keywords: Ischemic cardiomyopathy; Left ventricular assist device; Outflow graft obstruction; Percutaneous endovascular intervention |
| تواريخ الأحداث: | Date Created: 20240526 Latest Revision: 20240526 |
| رمز التحديث: | 20240527 |
| DOI: | 10.1016/j.carrev.2024.05.017 |
| PMID: | 38797580 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1878-0938 |
|---|---|
| DOI: | 10.1016/j.carrev.2024.05.017 |